EMERGING DIABETES MEDICATIONS : SAXENDA, RYBELSUS & MOUNJARO IN THE BRITAIN

Several novel therapies are now present in the UK for controlling glucose intolerance. Wegovy , Rybelsus , and Trulicity represent different approaches, with copyright and Trulicity being injectable peptide receptor agonists primarily aimed at weight management alongside blood sugar stabilization